Myomo (MYO) Net Income (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 20.92% |
| Jun 30, 2025 | -33.68% |
| Mar 31, 2025 | -152.78% |
| Dec 31, 2024 | 779.29% |
| Sep 30, 2024 | 13.84% |
| Jun 30, 2024 | 70.76% |
| Mar 31, 2024 | -161.30% |
| Dec 31, 2023 | 408.36% |
| Sep 30, 2023 | -100.07% |
| Jun 30, 2023 | 61.65% |
| Mar 31, 2023 | -12.61% |
| Dec 31, 2022 | 17.02% |
| Sep 30, 2022 | 2.72% |
| Jun 30, 2022 | -3.34% |
| Mar 31, 2022 | 4.40% |
| Dec 31, 2021 | -43.14% |
| Sep 30, 2021 | 21.53% |
| Jun 30, 2021 | 11.47% |
| Mar 31, 2021 | -130.06% |
| Dec 31, 2020 | 454.80% |
| Sep 30, 2020 | 15.53% |
| Jun 30, 2020 | 13.55% |
| Mar 31, 2020 | -53.60% |
| Dec 31, 2019 | 11.22% |
| Sep 30, 2019 | -8.68% |
| Jun 30, 2019 | 1.26% |
| Mar 31, 2019 | 14.76% |
| Dec 31, 2018 | -14.44% |
| Sep 30, 2018 | -1.17% |
| Jun 30, 2018 | -11.50% |
| Mar 31, 2018 | -29.89% |
| Dec 31, 2017 | -22.94% |
| Sep 30, 2017 | 28.92% |
| Jun 30, 2017 | -35.79% |
| Mar 31, 2017 | 8.11% |
| Dec 31, 2016 | -96.23% |
| Sep 30, 2016 | -37.60% |